| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |